All Studies

A network pharmacology and molecular docking approach in the exploratory investigation of the biological mechanisms of lagundi (Vitex negundo L.) compounds against COVID-19.

Researchers used network pharmacology and molecular docking to identify potential targets of Vitex negundo compounds against COVID-19. Results suggest that these compounds may interact with important proteins involved in the disease. However, further research is needed to fully understand their mechanisms and effectiveness.

Rivera RG et al (2023).
Genomics Inform.
PubMed:
37037462

Discovery and characterization of the covalent SARS-CoV-2 3CL(pro) inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches.

Study investigates how natural and synthetic compounds modify coronavirus proteases. Identifying herbal constituents that target these proteases is challenging but holds potential for COVID-19 treatment.

Zhang YN et al (2023).
Phytomedicine.
PubMed:
37037086

The effect of Nigella sativa (black seed) on biomarkers of inflammation and oxidative stress: an updated systematic review and meta-analysis of randomized controlled trials.

Kavyani Z et al (2023).
Inflammopharmacology.
PubMed:
37036558